Scholars Central

EditorialPublished 29 May 2025

RNAi Therapeutics: Promise, Challenges, Future

Authors: Dr. Ahmed Al-Sayed

Department of Molecular Genetics, Cairo University, Egypt

Cellular and Molecular Biology

Volume 71 · Issue 3 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

RNA interference (RNAi) is a vital gene silencing mechanism that includes siRNAs and miRNAs, critical for regulating gene expression and holding therapeutic promise. Significant progress has been made in RNAi-based therapeutics, targeting previously undruggable genes, with applications in cancer, antiviral strategies, and neurodegenerative diseases. While delivery systems, stability, and off-target effects remain challenges, innovative solutions like nanocarriers and advanced modifications are enhancing efficacy. The combination of RNAi with CRISPR/Cas9 further expands its potential. Continued research focuses on optimizing these technologies for widespread clinical success.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cellular and Molecular Biology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCellular and Molecular Biology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Dr. Ahmed Al-Sayed”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels